Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD), a hepatic manifestation of metabolic syndrome (MetS), is common and accounts for 80% of cases of elevated liver function tests (LFTs). We assessed the long-term effects of multifactorial intervention on LFTs and their association with cardiova...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Athyros, Vassilios G., Giouleme, Olga, Ganotakis, Emmanouel S., Elisaf, Moses, Tziomalos, Konstantinos, Vassiliadis, Themistoklis, Liberopoulos, Evangelos N., Theocharidou, Eleni, Karagiannis, Asterios, Mikhailidis, Dimitri P.
Format: Artigo
Idioma:Inglês
Publicat: Termedia Publishing House 2011
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3258797/
https://ncbi.nlm.nih.gov/pubmed/22291824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2011.25554
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars